MedRhythms is at the forefront of developing innovative neurotherapeutics aimed at enhancing walking and mobility through a proprietary technology platform. With a mission to empower patients to walk confidently, the company utilizes a unique combination of sensors, software, and music to deliver evidence-based interventions that target the human motor system. MedRhythms is committed to advancing patient-centered medical devices, having collaborated with prestigious research institutions for clinical trials. Their lead product, InTandem, is an FDA-authorized device designed to improve walking in adults with chronic stroke. The company values diversity and a people-first culture, fostering a hybrid workforce that integrates remote and on-site team members in Portland, Maine.